Dr. Joseph Fasanello, M.D
NPI: 1366769796
Total Payments
$2,125
2023 Payments
$51.54
Companies
19
Transactions
128
Medicare Patients
3,235
Medicare Billing
$204,204
Payment Breakdown by Category
Food & Beverage$2,116 (99.6%)
Education$9.08 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,116 | 126 | 99.6% |
| Education | $9.08 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $479.10 | 29 | $0 (2019) |
| GlaxoSmithKline, LLC. | $426.30 | 40 | $0 (2019) |
| Lilly USA, LLC | $190.20 | 13 | $0 (2019) |
| PFIZER INC. | $174.31 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $163.80 | 9 | $0 (2019) |
| Allergan Inc. | $123.33 | 1 | $0 (2018) |
| Mazor Robotics Inc. | $97.91 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $84.36 | 6 | $0 (2021) |
| Novo Nordisk Inc | $82.97 | 5 | $0 (2018) |
| ABBVIE INC. | $67.50 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $51.54 | 3 | ABBVIE INC. ($51.54) |
| 2022 | $15.96 | 1 | ABBVIE INC. ($15.96) |
| 2021 | $38.27 | 2 | Abbott Laboratories ($21.14) |
| 2020 | $13.32 | 1 | Merck Sharp & Dohme Corporation ($13.32) |
| 2019 | $369.61 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($110.11) |
| 2018 | $621.25 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($184.15) |
| 2017 | $1,015 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($184.84) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: VACCINE | ||||||
| 10/07/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Neuromodulation | ||||||
| 01/17/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: VACCINE | ||||||
| 08/30/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 08/23/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: VACCINES | ||||||
| 08/05/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/23/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: DIABETES | ||||||
| 06/20/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 06/05/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/03/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: DIABETES | ||||||
| 05/08/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 04/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: DIABETES | ||||||
| 04/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: DIABETES | ||||||
| 04/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 766 | 878 | $164,602 | $64,081 |
| 2022 | 15 | 851 | 941 | $193,302 | $44,018 |
| 2021 | 15 | 923 | 1,025 | $212,575 | $47,029 |
| 2020 | 14 | 695 | 793 | $151,276 | $49,076 |
Total Patients
3,235
Total Services
3,637
Medicare Billing
$204,204
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 139 | 139 | $33,834 | $17,185 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 182 | $43,822 | $15,383 | 35.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 125 | 192 | $26,115 | $11,113 | 42.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $9,725 | $5,941 | 61.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 82 | $13,745 | $4,488 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $2,687 | $2,435 | 90.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 40 | 40 | $10,816 | $1,603 | 14.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $3,332 | $1,439 | 43.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 45 | 46 | $7,927 | $1,301 | 16.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $2,852 | $1,239 | 43.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $3,038 | $944.32 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,561 | $473.55 | 30.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 24 | 27 | $2,834 | $382.05 | 13.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $2,314 | $153.86 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 220 | $52,941 | $11,297 | 21.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 106 | 150 | $25,086 | $8,674 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $36,896 | $8,056 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 84 | 86 | $23,255 | $3,358 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 57 | $9,554 | $2,547 | 26.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 26 | $1,877 | $1,772 | 94.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 63 | 63 | $10,857 | $1,751 | 16.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $3,635 | $1,582 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 38 | $3,137 | $1,087 | 34.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $1,718 | $862.61 | 50.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 15 | 19 | $1,522 | $739.93 | 48.6% |
About Dr. Joseph Fasanello, M.D
Dr. Joseph Fasanello, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in West Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1366769796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Fasanello, M.D has received a total of $2,125 in payments from pharmaceutical and medical device companies, with $51.54 received in 2023. These payments were reported across 128 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,116).
As a Medicare-enrolled provider, Fasanello has provided services to 3,235 Medicare beneficiaries, totaling 3,637 services with total Medicare billing of $204,204. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location West Amherst, NY
- Active Since 04/25/2010
- Last Updated 06/12/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366769796
Products in Payments
- JARDIANCE (Drug) $388.06
- ANORO (Drug) $208.76
- ELIQUIS (Drug) $139.05
- DALVANCE (Drug) $123.33
- FARXIGA (Drug) $97.73
- TRELEGY ELLIPTA (Drug) $88.26
- TRULICITY (Drug) $80.87
- TRADJENTA (Drug) $76.55
- BREO (Drug) $73.39
- BEVESPI AEROSPHERE (Drug) $66.07
- STIOLTO (Drug) $55.17
- TOUJEO (Drug) $55.04
- JANUVIA (Drug) $53.91
- VRAYLAR (Drug) $51.54
- SPIRIVA (Drug) $47.41
- Saxenda (Drug) $36.31
- Victoza (Drug) $35.05
- ORBACTIV (Drug) $30.87
- Myrbetriq (Drug) $22.68
- VYVANSE (Drug) $22.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.